Paroxysmal Nocturnal Hemoglobinuria (PNH)

Daria Babushok, MD, PhD

Institution
Hospital of the University of Pennsylvania
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Daria Babushok’s research is focused on understanding the genetic changes that can arise in the bone marrow of patients with aplastic anemia, and on how they affect the patients’ prognosis and treatment outcomes. Dr. Babushok has completed a clinical hematology-oncology fellowship at the Hospital of the University of Pennsylvania, and is currently a junior physician-scientist investigator at the University of Pennsylvania under the mentorship of Dr. Monica Bessler. In a study recently published in the journal of Cancer Genetics and conducted with the support of the AA&MDS International

PNH Foundation Announces Grants For Patients

The PNH Research and Support Foundation seeks to ensure that all PNH patients can see a PNH specialist to pursue the best course of treatment. The Foundation also helps patients with costs related to stem cell transplants in cases where this treatment is required. The PNH Foundation may be able to provide financial aid up to $3,000 per eligible, U.S.-based PNH patient with demonstrated financial need for the following costs:

David Margolis, MD

Institution
Children’s Hospital of Wisconsin
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric
About
David Margolis, MD, received his medical degree from the University of Wisconsin-Madison in 1989. He is currently a professor of pediatrics at the Medical College of Wisconsin, located in Milwaukee, and is program director of Children’s Hospital of Wisconsin’s Blood and Bone Marrow Transplant Program. His clinical and research interests include taking care of children and young adults with aplastic anemia as well as alternative donor blood and bone marrow transplants for children and young adults with aplastic anemia, sickle cell anemia and leukemia.

Blood Transfusion Safety and Risks

Negative side effects of blood transfusion therapy are uncommon. Blood banks, hospitals, and health-care providers take many precautions to minimize risks before each blood transfusion.

Blood banks test each unit of blood to find out its ABO type and Rh status. In the United States, after a hospital laboratory receives a blood unit from the blood bank, the laboratory tests the unit again.

 

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.